Could a blood clot drug ease arthritis pain?

NCT ID NCT05671497

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether cilostazol, a drug normally used for leg pain from blocked arteries, can help control rheumatoid arthritis when added to standard medications. 70 adults with moderate to severe arthritis took either cilostazol plus their usual drugs or just their usual drugs for 6 months. The goal was to see if cilostazol reduces joint swelling, pain, and inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cilostazol
What this could lead to
If it works, this could point toward a new, affordable add-on treatment to better control rheumatoid arthritis symptoms.
What could go wrong
This is a small, completed Phase 2/3 trial with only 70 participants. Results may not apply to all patients, and cilostazol can cause side effects like headache or heart issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Al-Zahraa Hospital

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.